González SÁG, Larrondo MHM, Pérez MY

Language: Spanish
References: 9
Page: 1-6
PDF size: 289.65 Kb.

ABSTRACT

Two patients admitted to a multipurpose intensive care ward were studied. They showed epidemic toxic necrolysis (NTE), a rare complication that has an incidence of 1 to 4 cases per million inhabitants. Drugs were the cause of the disease in these patients and the main drugs involved were amphotericin B and ciprofloxacin. This is the first case of NTE related to the use of Liposomal Amphotericin B reported in Cuba and in the rest of the scientific community, which makes it interesting. The diagnosis was confirmed by skin biopsy, both patients had risk of death, according to the Scorten index, higher than 50%. This research was carried out with the aim of communicating the experience and knowledge to the medical and scientific community in general and to the professionals who work in multipurpose intensive care rooms in particular, since this condition is rare in a multipurpose intensive care room, it is rare in relation to the aforementioned antibiotics, its dramatic clinical status and the torpid evolution of patients.

REFERENCES

1. Domínguez Borgúa A, González I, Morales L, Martínez Carrillo FM, Palacios P. Necrolisis epidérmica toxica y desarrollo de abscesos hepáticos, Gac Med Mex. 2015;151:512-8.

2. Martínez Cabrales SA, Gómez Flores M, Ocampo Candiani J. Actualidades en farmacodermias severas: síndrome de Stevens Johnson y necrolisis epidérmica toxica, Gac Med Mex. 2015;151:777-87.

3. Hoetzenecker W, Mehra T, Saulite I, Glatz M, Schmid-Grendelmeier P, Guenova A, Cozzio E, et al. Toxic epidermal necrolysis. Faculty Rev. 2016. Doi: https://doi.org//10.12688/f1000research.7574.1

4. Arias DA, Londoño PA, López JG. Síndrome de Stevens- Johnson y necrolisis epidérmica tóxica en el Hospital Universitario del Valle "Evaristo García" durante un período de 9 años. Rev Asoc Colomb Dermatol. 2013[acceso: 20/05/2016];21(3):214-19. Disponible en: http://revistasocolderma.org/files/Stevens%20Jhonson%20y%20necrolisis%20epidermica.pdf

5. Mawson AR, Eriator I, Karre S. Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN): could retinoids play a causative role? Med Sci Monit. 2015;12(21):133-43.

6. Valdez Mesa S, Planas Pavón M, Benítez Martínez I. Necrolisis tóxica epidérmica: particularidades de su atención. Rev Cub Med Mil. 2007[acceso: 20/05/2016];36(3). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0138-65572007000300009&lng=es

7. Nicoletti P, Bansal M, Lefebvre C, Guarnieri P, Shen Y, Pe'er I, et al. Floratos. ABC transporters and the proteasome complex are implicated insusceptibility to Stevens-Johnson syndrome and toxic epidermal necrolysis across multiple drugs. PLoS One. 2015[acceso: 20/05/2016];10(6). Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4482486/

8. Lerch M, Mainetti C, Terziroli Beretta-Piccoli B. Current perspectives on Stevens-Johnson syndrome and toxic epidermal necrolysis. Clin Rev Allergy Immunol. 2018;54(1):147-76.

9. Estrella Alonso A, Aramburu JA, González-Ruiz MY, Cachafeiro L, Sánchez Sánchez M, Lorente JA. Rev Bras Ter Intensiva. 2017;29(4):499-508.